Pleurodesis for malignant pleural effusions

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 11, 2013, Pages

  Shaw, Paul H S ^a   Agarwal, Roshan ^b  

^a VELINDRE CANCER CENTRE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRIORITY JOURNAL; RETRACTED ARTICLE; REVIEW;

EID: 85041749511     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD002916.pub3     Document Type: Review

References (64)

1. Bjermer L, Gruber A, Sue-Chu M, Sandstrom T, Eksborg S, Henriksson R. Effects of intrapleural mitoxabtrone and meparcine on malignant pleural effusion -- A randomised study. European Journal of Cancer 1995;31A:2203-8.
2. Clementsen P, Evald T, Grode G, Hansen G, Jacobsen K, Faurschou P. Treatment of malignant pleural effusion: Pleurodesis using a small percutaneous catheter. A prospective randomised study. Respiratory Medicine 1998;92:593-6.
3. Diacon A, Wyser C, Bolliger C, Tamm M, Pless M, Perruchoud A, et al. Prospective randomised comparison of thoracoscopic talc poudrage under local anaethesia versus bleomycin instillation for pleurodesis in malignant pleural effusion. Am J Respir Crit Care Med 2000;162:1445-9.
4. Emad A, Rezaian G. Treatment of malignant pleural effusions with a combination of bleomycin and tetracycline. Cancer 1996;78:2498-501.
5. Fentiman I, Rubens R, Hayward J. Control of pleural effusions in patients with breast cancer. Cancer 1983;52:737-9.
6. Fentiman I, Rubens R, Hayward J. A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. European Journal Clinical Oncology 1986;22:1079-81.
7. Groth G, Gatzemeier U, Haussingen K, Heckmayer M, Magnussen H, Neuhauss R, et al. Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Annals of Oncology 1991;2:213-5.
8. Gupta N, Opfell R, Padova J, Margileth D, et al. Intrapleural bleomycin versus tetracycline for control of malignant pleural effusion: A randomised study. ASCO Abstracts 1980;C-189:366.
9. Gust R, Kleine P, Fabel H. [Fibrin sealant and tetraclinpleurodese with recurrent pleural effusion malignan]. Medical Clinic 1990;85:18-23.
10. Hamed H, Fentiman I, Chaudary M, Rubens R. Comparison of intracavitary bleomycin and talc for control of pleural effusion secondary to carcinoma of the breast. British Journal of Surgery 1989;76:1266-7.
11. Hillerdal G, Kiviloog J, Nou E, Steinholtz L. Corynebacterium parvum in malignant pleural effusion. A randomised prospective study. European Journal of Respiratory Diseases 1986;69:204-6.
12. Evans TR, Stein RC, Pepper JR, Gazet JC, Ford HT, Coombes RC. A randomised prospective trial of surgical against medical tetracycline pleurodesis in the management of malignant pleural effusions secondary to breast cancer. European Journal of Cancer 1993;29A:316-9.
13. Johnson C, Curzon P. Comparison of intrapleural bleomycin and tetracycline in the treatment of malignant pleural effusion. Proceedings of the British Thoracic Society. 1985; Vol. 40:210.
14. Kessinger A, Wigton R. Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: A randomised study. Journal of Surgical Oncology 1987;36:81-3.
15. Koldsland S, Svennevig J, Lehne G, Johnson E. Chemical pleurodesis in malignant pleural effusions: A randomised prospective study of mepacrine versus bleomycin. Thorax 1993;48:790-3.
16. Leahy B, Honeybourne D, Brear S, Carroll K, Thatcher N, Stretton T. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline. European Journal of Respiratory Diseases 1985;66:50-4.
17. Leverenz A, Heckmayr M, Tischer-Neuhauss R, Gatzemeier U. Intrapleural palliative treatment of malignant pleural effusions with talcum versus placebo (pleural tube alone). Lung Cancer 2000;29A((suppl 1)):274.
18. Loutsidis A, Bellenis I, Argiriou M, Exarchos N. Tetracycline compared with mechlorethamine in the treatment of malignant pleural effusions. A randomised trial. Respiratory Medicine 1994;88:523-6.
19. Lynch T, Kalish L, Menzter S, Decamp M, Strauss G, Sugarbaker D. Optimal therapy of malignant pleural effusions: Report of a randomised trial of bleomycin, tetracycline and talc and a meta analysis. International Journal of Oncology 1996;8:183-90.
20. Manes N, Rodriguez-Panadero F, Bravo J, Hernandez H, Alix A. Talc pleurodesis. Prospective and randomised study. Chest 2000;118(4):131s.
21. Martinez-Moragon E, Aparicio J, Rogado M, Sanchis J, Sanchis F, Gil-Suay V. Pleurodesis in malignant pleural effusion: a randomised study of tetracycline versus bleomycin. European Respiratory Journal 1997;10:2380-3.
22. Noppen M, Degreve J, Mignolet M, Vincken W. A prospective randomised study comparing the efficacy of talc slurry and bleomycin in the treatment of malignant pleurla effusions. Acta Clinica Belgica 1997;52-4:258.
23. O'Neill W, Spurr C, Muss H, Richards F, White D, Cooper M. A prospective study of chest tube drainage and tetracycline sclerosis versus chest tube drainage alone in the treatment of malignant pleural effusion. American Society of Clinical Oncology (Abstracts) 1980;March:349.
24. Ong K, Indumathi V, Raghuram J, Ong Y. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions. Respirology 2000;5:99-103.
25. Ostrowski M, Priestman R, Houston R, Martin W. A randomised trial of intracavitary bleomycin and Cporynebacterium parvum in the control of malignant pleural effusions. Radiotherapy and Oncology 1989;14:19-26.
26. Patz E, McAdams H, Erasmus J, Goodman P, Culhane D, Gilkeson R, et al. Sclerotherapy for malignant pleural effusionsleomycin: A prospective randomised trial of bleomycin versus doxycyline with small bore catheter drainage. Chest 1998;113:1305-11.
27. Ruckdeschel J, Moores D, Lee J, Einhorn L, Mandelbaum I, Koeller J, et al. Intrapleural therapy for malignant pleural effusion: A randomised comparison of bleomycin and tetrecycline. Chest 1991;100:1528-35.
28. Salomaa E, Pulkki K, Helenius. Pleurodesis with doxcycline or Corynebacterium parvum in malignant pleural effusion. Acta Oncologica 1995;34:117-21.
29. Sartori S, Trevisant L, Nielsen I, Anna A, Tassinari D, Civile O, et al. Intracavitary bleomycin versus interferon in the management of malignant pleural effusions. Chest 1998;113(4):1145-6.
30. Schmidt M, Schaarschmidt G, Chemaissani A. Pleurodesis in malignant pleural effusion: bleomycin vs. mitoxantrone [Pleurodese bei malignem Pleuraerguss: Bleomycin vs. Mitoxantron]. Pneumologie 1997;51(4):367-72.
31. Sorensen P, Svensen T, Enk B. Treatment of malignant pleural effusionwith drainage, with and without talc. European Journal of Respiratory Diseases 1984;65:131-5.
32. Kefford RF, Woods RL, Fox RM, Tatterall MH. Intracavitary adriamycin nitrogen mustard and tetracycline in the control of malignant effusions: A randomised study. Medical Journal of Australia 1980;2:447-8.
33. Won Sup O, Choi J, Kim Y, Do Y, Jang T, Jung M. Intrapleural doxycyline and bleomycin in the management of malignant pleural effusions: A randomised study. Tuberculosis and Respiratory Disease 1997;44(1):85.
34. Yim A, Chan A, Lee T, Wan I, Ho J. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Annals of Thoracic Surgery 1996;62:1655-8.
35. Zaloznik A, Oswald S, Langin M. Intrapleural tetracycline in malignant pleural effusions: A randomised study. Cancer 1983;51:752-5.
36. Zimmer P, Hill M, Casey K, Harvey E, Low D. Prospective randomised trial of talc slurry versus bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest 1997;112:430-4.
37. Engel J. [Tetracyclin- und Na-OH-pleurodese in der palliativbehandlung maligner pleuraergusse]. Prax Pneumol 1981;35:1124-8.
38. Hartman D, Gaither J, Kesler K, Mylet D, Brown J, Mathur P. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. Journal of Thoracic & Cardiovascular Surgery 1993;105:743-8.
39. Kelly-Garcia J, Roman-Beruman J, Ibarra-Perez C. Iodopovidine and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms. Archives of Medical Research 1997;28(4):583-5.
40. Kwen-Tay L, Yang P, Kuo S, Chang D, Yu C, Lee L. Comparison of OK-432 and Mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. Cancer 1992;69:674-9.
41. Landvater L, Hix W, Mills M, Siegel R, Aaron B. Malignant pleural effusion treated by tetracycline sclerotherapy: A comparison of single versus repeated instillation. Chest 1988;93(6):1196.
42. Lissoni P, Barni S, Tancini G, Ardizzoia Tisi E, Angeli M, Rizzi A. Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin 2. Supportive Care Cancer 1995;3:78-80.
43. Mager H, Maesen B, Verzijlbergen F, Schramel F. Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis. Lung Cancer 2002;36:77-81.
44. Maiche A, Virkkunen P, Kontkanen T, Moykkynen K, Porkka K. Bleomycin and mitoxantrone in the treatment of malignant pleural effusions. American Journal of Clinical Oncology 1993;16:50-3.
45. Masuno T, Kishimoto S, Ogura T, Honma T, Niitani H, Fukuoka M, et al. A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer. Cancer 1991;68:1495-1500.
46. Moores D. Malignant pleural effusion. Seminars in Oncology 1991;18(1, Supplement 2):59-61.
47. Nio Y, Nagami H, Tamura K, Tsubono M, Nio M, Sato M, et al. Multi-institutional randomised clinical study on the comparative effects of intracavitary chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant pleural effusion. British Journal of Cancer 1999;80(5/6):775-85.
48. Putman J, Light R, Rodriguez M, Ponn R, Olak J, Pollak, J, Lee R, et al. A randomised comparison of indwelling pleural catheter and doxycyline pleurodesis in the management of malignant pleural effusions. Cancer 1999;86:1992-9.
49. Senyigit A, Bayram H, Babayigit C, Tpocu F, Balci A, Satici O. Comparison of the effectiveness of some pleural sclerosing agents used for control of effusions in malignant pleural mesothelioma: A review of 117 cases. Respiration 2000;67:623-9.
50. Urata A, Nishimura M, Ota K. Randomised controlled study of OK 432 in the treatment of cancerous pleurisy. Japanese Journal of Cancer Chemotherapy 1983;10(6):1497-503.
51. Vargas F, Carmo A, Teixeira L. A new look at old agents for pleurodesis: nitrogen mustard, sodium hydroxide and silver nitrate. Current Opinion in Pulmonary Medicine 2000;6:281-6.
52. Yew W, Chan S, Kwan S. Comparison of efficacy of Mitomycin C and Corynebacterium parvum in the management of malignant pleural effusion. Chinese Medical Journal 1988;101(10):737-9.
53. Aguilar F, Baldi M, Serrano L, Boer M, Saad E. Utilization of talc as a chemical agent in pleurodesis from malignant pleural effusion. Prensa Medica Argentina 2001;88(1):22-4.
54. Foroulis C, Kotoulas C, Konstatinou M, Lioulias A. The management of malignant pleural effusion: Talc pleurodesis versus bleomycin. Journal of Buon 2001;6(4):397-400.
55. Parulekar W, Di-Primio G, Matzinger F. Use of small bore vs large bore chest tubes for treatment of malignant pleural effusion. Chest 2001;120:19-25.
56. Seijo LM, Sterman D. Treatment of mesotheliomatous pleural effusion: Experimental therapy versus thoracoscopic talc poudrage. Journal of Bronchology 2001;8:47-53.
57. Villanueva A, Gray A, Shahian D, Williamson W, Beamis J. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusion. Thorax 1994;49:23-5.
58. Zhang Z, Li D, Wu Z. Treatment of malignant pleural effusion using vindesine and cisplatine intrapleurally injection observation of 60 cases). Zhonghua Jie He He Hu Xi Za Zhi 2001;24:29-31.
59. Anthony V, Loodenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J. Management of malignant pleural effusions. American Journal of Respiratory and Critical Care Medicine 2000;162(5):1987-2001.
60. Mulrow CD, Oxman AD (eds). Library of Examples. "Quality scale assessment. In: Mulrow CD, Oxman AD editor(s). Section 6. In: The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration. Oxford: Update Software, 1997:113.
61. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. http://www.jr2.ox.ac.uk/bandolier/booth/painpg/NNTstuff/numeric.htm Accessed May 2002.
62. National Cancer Institute. Common Toxxicity Criteria Version 2.0 30 April 1999. http://ctep.cancer.gov/reporting/ctc.html Accessed April 2002.
63. Spiegler PA, Hurewitz AN, Groth ML. Rapid pleurodesis for malignant pleural effusions. Chest 2003;123:1895-8.
64. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Annals of Internal Medicine 1994;120(1):56-64.